[go: up one dir, main page]

TH1601000099A - Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation. - Google Patents

Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation.

Info

Publication number
TH1601000099A
TH1601000099A TH1601000099A TH1601000099A TH1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A TH 1601000099 A TH1601000099 A TH 1601000099A
Authority
TH
Thailand
Prior art keywords
anticholinergic
corticosteroid
adrenergic
inhalation
beta
Prior art date
Application number
TH1601000099A
Other languages
Thai (th)
Other versions
TH159392A (en
Inventor
มูซ่านางสาวไอรีน ปาสควาลีนายอะซิต้า อัสกี้ ซาร์วาร์นายฟรานเซลก้า เชียร์เรตตี นายรอสเซลล่า
Original Assignee
กีเอซี ฟาร์มาเชอูตีชี เอสพีเอ
Filing date
Publication date
Application filed by กีเอซี ฟาร์มาเชอูตีชี เอสพีเอ filed Critical กีเอซี ฟาร์มาเชอูตีชี เอสพีเอ
Publication of TH159392A publication Critical patent/TH159392A/en
Publication of TH1601000099A publication Critical patent/TH1601000099A/en

Links

TH1601000099A 2014-07-10 Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation. TH1601000099A (en)

Publications (2)

Publication Number Publication Date
TH159392A TH159392A (en) 2017-01-18
TH1601000099A true TH1601000099A (en) 2017-01-18

Family

ID=

Similar Documents

Publication Publication Date Title
IL273507A (en) Methods, devices and systems for pulmonary delivery of active agents
IL264454A (en) New preparations, uses and methods for their preparation
HUE073236T2 (en) Aroma inhaler
DK3332767T3 (en) Liquid inhalation formulation comprising RPL554
IL246837A0 (en) Antibodies, pharmaceutical compositions and uses thereof
DK3569222T3 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
ZA201902762B (en) Mission-critical push-to-talk
DK3107548T3 (en) DRY POWDER FORMULATIONS FOR INHALATION
DK3505209T3 (en) POWDER INHALATOR
DK3325059T3 (en) DRY POWDER INHALATOR
HRP20190397T1 (en) DOSAGE INHALATOR WITH DUST AND PROCEDURE FOR ITS MANUFACTURING
HUE054245T2 (en) Immunosuppressant formulation
DK3138600T3 (en) The dry powder inhaler
HUE056260T2 (en) Process for the preparation of a dry powder composition comprising an anticholinergic agent, a corticosteroid and a beta-adrenergic agent
DK3689379T3 (en) A process for the preparation of a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
HUE047860T2 (en) Pharmaceutical formulation comprising antibody
PL3040062T3 (en) Absorbent structure, and absorbent item comprising this absorbent structure
DK3179986T3 (en) DRY POWDER FORMULATIONS FOR INHALATION
HRP20180773T1 (en) SILDENAFIL SOLUTIONS, PROCEDURES FOR THEIR PREPARATION AND USE
BR112016025075A2 (en) agrochemical formulation.
IL249773A0 (en) Dry powder medicament de-agglomerator
SG11201700276QA (en) Quinoxaline compounds, method for preparing the same and use thereof
DK3212212T3 (en) POWDER FORMULATION
FR3021118B1 (en) SUPERCONDUCTING COMPONENT, AMPLIFIER
TH1601000099A (en) Dry powder formulation comprising an anticholinergic, corticosteroid. and beta-adrenergic for inhalation.